Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kadri Altundag

Showing results (61-70 of 151) with videos related to

Pageof 16
Sort By:
The American Surgeon|August 30, 2023
Secretory Carcinoma of Breast: A Population-Based StudyAhmet Necati Sanli, Deniz Esin Tekcan Sanli, M Kadri Altundag, et al.
The Annals of Pharmacotherapy|March 18, 2003
Recurrent cholestasis due to ampicillinSeyfettin Köklü, Osman Yüksel, Levent Filik, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 24, 2017
The short-term safety of adjuvant paclitaxel plus trastuzumab - A single centre experienceOzturk Ates, Veli Sunar, Alma Aslan, et al.
Medical Oncology (Northwood, London, England)|January 16, 2008
Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastasesMurat Dincer, Kadri Altundag, Hakan Harputluoglu, et al.
Medical Oncology (Northwood, London, England)|June 26, 2012
Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: a single center experienceErkan Dogan, Hikmet Yorgun, Ibrahim Petekkaya, et al.
The American Surgeon|October 24, 2012
Lymphatic and capillary invasion patterns in triple negative breast cancerSebnem Yaman, Berrak Gumuskaya, Cigdem Ozkan, et al.
Cancer Genetics and Cytogenetics|December 16, 2010
EGFR expression and gene copy number in triple-negative breast carcinomaBerrak Gumuskaya, Murat Alper, Sema Hucumenoglu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 2, 2010
Zoledronic acid and atrial fibrillation in cancer patientsCagatay Arslan, Sercan Aksoy, Omer Dizdar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 17, 2013
Complete response and long-term remission to anti-HER2 combined therapy in a patient with breast cancer presented with bone marrow metastasesMehmet Artac, Lokman Koral, Hatice Toy, et al.
Medical Oncology (Northwood, London, England)|June 21, 2005
Acute tumor lysis syndrome triggered by zoledronic Acid in a patient with metastatic lung adenocarcinomaMevlut Kurt, Ibrahim K Onal, Tamer Elkiran, et al.
Pageof 16

Showing results (61-70 of 151) with videos related to

Sort By:
Pageof 16
The American Surgeon|August 30, 2023
Secretory Carcinoma of Breast: A Population-Based StudyAhmet Necati Sanli, Deniz Esin Tekcan Sanli, M Kadri Altundag, et al.
The Annals of Pharmacotherapy|March 18, 2003
Recurrent cholestasis due to ampicillinSeyfettin Köklü, Osman Yüksel, Levent Filik, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|May 24, 2017
The short-term safety of adjuvant paclitaxel plus trastuzumab - A single centre experienceOzturk Ates, Veli Sunar, Alma Aslan, et al.
Medical Oncology (Northwood, London, England)|January 16, 2008
Renal safety of zoledronic acid administration beyond 24 months in breast cancer patients with bone metastasesMurat Dincer, Kadri Altundag, Hakan Harputluoglu, et al.
Medical Oncology (Northwood, London, England)|June 26, 2012
Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: a single center experienceErkan Dogan, Hikmet Yorgun, Ibrahim Petekkaya, et al.
The American Surgeon|October 24, 2012
Lymphatic and capillary invasion patterns in triple negative breast cancerSebnem Yaman, Berrak Gumuskaya, Cigdem Ozkan, et al.
Cancer Genetics and Cytogenetics|December 16, 2010
EGFR expression and gene copy number in triple-negative breast carcinomaBerrak Gumuskaya, Murat Alper, Sema Hucumenoglu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 2, 2010
Zoledronic acid and atrial fibrillation in cancer patientsCagatay Arslan, Sercan Aksoy, Omer Dizdar, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 17, 2013
Complete response and long-term remission to anti-HER2 combined therapy in a patient with breast cancer presented with bone marrow metastasesMehmet Artac, Lokman Koral, Hatice Toy, et al.
Medical Oncology (Northwood, London, England)|June 21, 2005
Acute tumor lysis syndrome triggered by zoledronic Acid in a patient with metastatic lung adenocarcinomaMevlut Kurt, Ibrahim K Onal, Tamer Elkiran, et al.
Pageof 16